Literature DB >> 27146410

Risk factors and morbidity of infantile haemangioma: preterm birth promotes ulceration.

Eeva Castrén1, Päivi Salminen2, Mika Gissler3, Vedran Stefanovic4, Anne Pitkäranta1, Tuomas Klockars1.   

Abstract

AIM: We identified the characteristics of an infantile haemangioma (IH) that predispose children to complications, interventions and long-term morbidity and examined perinatal risk factors for IH.
METHODS: We studied children with IHs admitted to Helsinki University Hospital's paediatric vascular anomaly clinic in Finland in 2004-2007 and registered perinatal records, IH characteristics, complications and interventions. These patients received a questionnaire on perinatal data and long-term morbidity resulting from IH. We analysed factors related to complications, interventions and morbidity and compared our cohort's perinatal data to the Finnish Medical Birth Register (FMBR) figures.
RESULTS: We approached 185 families, of which 136 replied to the questionnaire. Children with facial, segmental and indeterminate IHs showed more complications, interventions and higher long-term morbidity. Preterm birth predisposed infants to ulceration of IHs, with a 95% confidence interval (CI) of 1.02-5.14 and odds ratio (OR) of 2.29. In addition to earlier known risks, maternal gestational diabetes mellitus rate was higher in our IH cohort than the rate in the FMBR (95% CI 1.39-4.95, OR 2.62).
CONCLUSION: Physicians treating IHs should consider the elevated ulceration risk in preterm infants. The association between gestational diabetes mellitus and child's risk for an IH is uncertain and requires further research. ©2016 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Gestational diabetes mellitus; Infantile haemangioma; Preterm; Vascular anomalies; Vascular tumour

Mesh:

Year:  2016        PMID: 27146410     DOI: 10.1111/apa.13460

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  5 in total

1.  Maternal and Perinatal Risk Factors for Infantile Hemangioma: A Matched Case-Control Study with a Large Sample Size.

Authors:  Xue Gong; Tong Qiu; Liwei Feng; Kaiying Yang; Shiyi Dai; Jiangyuan Zhou; Xuepeng Zhang; Siyuan Chen; Yi Ji
Journal:  Dermatol Ther (Heidelb)       Date:  2022-06-25

2.  Impact of congenital cutaneous hemangiomas on newborn care in the United States.

Authors:  Raghav Tripathi; Rishabh S Mazmudar; Konrad D Knusel; Harib H Ezaldein; Leah T Belazarian; Jeremy S Bordeaux; Jeffrey F Scott
Journal:  Arch Dermatol Res       Date:  2020-10-19       Impact factor: 3.017

Review 3.  Interventions for infantile haemangiomas of the skin.

Authors:  Monica Novoa; Eulalia Baselga; Sandra Beltran; Lucia Giraldo; Ali Shahbaz; Hector Pardo-Hernandez; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2018-04-18

Review 4.  Current perspectives on the optimal management of infantile hemangioma.

Authors:  Peter Grzesik; June K Wu
Journal:  Pediatric Health Med Ther       Date:  2017-12-06

5.  Population Pharmacokinetics and Pharmacodynamics of Oral Propranolol in Pediatric Patients With Infantile Hemangioma.

Authors:  Tomoki Takechi; Tadao Kumokawa; Rumiko Kato; Takeshi Higuchi; Tsuyoshi Kaneko; Ichiro Ieiri
Journal:  J Clin Pharmacol       Date:  2018-05-10       Impact factor: 3.126

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.